Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Liver Diseases

  Free Subscription


Articles published in AJR Am J Roentgenol

Retrieve available abstracts of 81 articles:
HTML format
Text format



Single Articles


    May 2019
  1. CHEN J, Zhou J, Kuang S, Zhang Y, et al
    Liver Imaging Reporting and Data System Category 5 (LI-RADS LR-5): MRI Predictors of Microvascular Invasion and Recurrence After Hepatectomy for Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2019 May 23:1-10. doi: 10.2214/AJR.19.21168.
    PubMed     Text format     Abstract available


  2. DE HAAS RJ, Lim C, Ricci C, Lahat E, et al
    Local Ablation Does Not Worsen Perioperative Outcomes After Liver Transplant for Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2019 May 23:1-8. doi: 10.2214/AJR.18.20993.
    PubMed     Text format     Abstract available


  3. BOAS FE, Brown KT, Ziv E, Yarmohammadi H, et al
    Aspirin Is Associated With Improved Liver Function After Embolization of Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2019 May 23:1-7. doi: 10.2214/AJR.18.20846.
    PubMed     Text format     Abstract available


    April 2019
  4. KIM HO, Yim NY, Kim JK, Kang YJ, et al
    Change in Perfusion Angiography During Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Predicts Short-Term Outcomes.
    AJR Am J Roentgenol. 2019 Apr 30:1-8. doi: 10.2214/AJR.18.20499.
    PubMed     Text format     Abstract available


  5. VERNUCCIO F, Cannella R, Meyer M, Choudhoury KR, et al
    LI-RADS: Diagnostic Performance of Hepatobiliary Phase Hypointensity and Major Imaging Features of LR-3 and LR-4 Lesions Measuring 10-19 mm With Arterial Phase Hyperenhancement.
    AJR Am J Roentgenol. 2019 Apr 30:1-9. doi: 10.2214/AJR.18.20979.
    PubMed     Text format     Abstract available


  6. LIMA PH, Fan B, Berube J, Cerny M, et al
    Cost-Utility Analysis of Imaging for Surveillance and Diagnosis of Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2019 Apr 17:1-9. doi: 10.2214/AJR.18.20341.
    PubMed     Text format     Abstract available


  7. SMITH AD, Porter KK, Elkassem AA, Sanyal R, et al
    Current Imaging Techniques for Noninvasive Staging of Hepatic Fibrosis.
    AJR Am J Roentgenol. 2019 Apr 11:1-13. doi: 10.2214/AJR.19.21144.
    PubMed     Text format     Abstract available


    March 2019
  8. POOLER BD, Hernando D, Reeder SB
    Clinical Implementation of a Focused MRI Protocol for Hepatic Fat and Iron Quantification.
    AJR Am J Roentgenol. 2019 Mar 27:1-6. doi: 10.2214/AJR.18.20947.
    PubMed     Text format     Abstract available


  9. WANG L, Liu C, Liu J, Li P, et al
    MRI-Guided Cryoablation of Hepatic Dome Hepatocellular Carcinomas Using 1-T Open High-Field-Strength Scanner.
    AJR Am J Roentgenol. 2019 Mar 12:1-9. doi: 10.2214/AJR.18.19815.
    PubMed     Text format     Abstract available


    January 2019
  10. SARKAR S, Corwin MT, Olson KA, Stewart SL, et al
    Pilot Study to Diagnose Nonalcoholic Steatohepatitis With Dynamic (18)F-FDG PET.
    AJR Am J Roentgenol. 2019 Jan 23:1-9. doi: 10.2214/AJR.18.20012.
    PubMed     Text format     Abstract available


  11. VERNUCCIO F, Rosenberg MD, Meyer M, Choudhury KR, et al
    Negative Biopsy of Focal Hepatic Lesions: Decision Tree Model for Patient Management.
    AJR Am J Roentgenol. 2019 Jan 23:1-9. doi: 10.2214/AJR.18.20268.
    PubMed     Text format     Abstract available


    December 2018
  12. CANNELLA R, Rangaswamy B, Minervini MI, Borhani AA, et al
    Value of Texture Analysis on Gadoxetic Acid-Enhanced MRI for Differentiating Hepatocellular Adenoma From Focal Nodular Hyperplasia.
    AJR Am J Roentgenol. 2018 Dec 17:1-9. doi: 10.2214/AJR.18.20182.
    PubMed     Text format     Abstract available


    November 2018
  13. TADA T, Kumada T, Toyoda H, Kobayashi N, et al
    Utility of Attenuation Coefficient Measurement Using an Ultrasound-Guided Attenuation Parameter for Evaluation of Hepatic Steatosis: Comparison With MRI-Determined Proton Density Fat Fraction.
    AJR Am J Roentgenol. 2018 Nov 26:1-10. doi: 10.2214/AJR.18.20123.
    PubMed     Text format     Abstract available


    October 2018
  14. LAWRENCE EM, Pooler BD, Pickhardt PJ
    Opportunistic Screening for Hereditary Hemochromatosis With Unenhanced CT: Determination of an Optimal Liver Attenuation Threshold.
    AJR Am J Roentgenol. 2018 Oct 9:1-6. doi: 10.2214/AJR.18.19690.
    PubMed     Text format     Abstract available


    September 2018
  15. SHETTY AS, Mittal A, Salter A, Narra VR, et al
    Hepatopancreaticobiliary Imaging Second-Opinion Consultations: Is There Value in the Second Reading?
    AJR Am J Roentgenol. 2018 Sep 24:1-8. doi: 10.2214/AJR.17.19452.
    PubMed     Text format     Abstract available


  16. HORVAT N, Rocha MS, Chagas AL, Oliveira BC, et al
    Multimodality Screening of Hepatic Nodules in Patients With Congenital Heart Disease After Fontan Procedure: Role of Ultrasound, ARFI Elastography, CT, and MRI.
    AJR Am J Roentgenol. 2018 Sep 24:1-9. doi: 10.2214/AJR.18.19762.
    PubMed     Text format     Abstract available


  17. KIM J, Choi SJ, Lee SH, Lee HY, et al
    Predicting Survival Using Pretreatment CT for Patients With Hepatocellular Carcinoma Treated With Transarterial Chemoembolization: Comparison of Models Using Radiomics.
    AJR Am J Roentgenol. 2018 Sep 21:1-9. doi: 10.2214/AJR.18.19507.
    PubMed     Text format     Abstract available


  18. MARION-AUDIBERT AM, Vullierme MP, Ronot M, Mabrut JY, et al
    Routine MRI With DWI Sequences to Detect Liver Metastases in Patients With Potentially Resectable Pancreatic Ductal Carcinoma and Normal Liver CT: A Prospective Multicenter Study.
    AJR Am J Roentgenol. 2018 Sep 21:W1-W9. doi: 10.2214/AJR.18.19640.
    PubMed     Text format     Abstract available


    August 2018
  19. CHIEN A, Wang YL, McWilliams J, Lee E, et al
    Venographic Analysis of Portal Flow After TIPS Predicts Future Shunt Revision.
    AJR Am J Roentgenol. 2018 Aug 7:684-688. doi: 10.2214/AJR.17.19287.
    PubMed     Text format     Abstract available


  20. FURLAN A, Brancatelli G, Vilgrain V
    Reply to "Oxaliplatin-Induced Liver Changes on Gadoxetate Disodium-Enhanced Liver MRI".
    AJR Am J Roentgenol. 2018;211:W134.
    PubMed     Text format    


  21. UNAL E, Karcaaltincaba M
    Oxaliplatin-Induced Liver Changes on Gadoxetate Disodium-Enhanced Liver MRI.
    AJR Am J Roentgenol. 2018;211:W133.
    PubMed     Text format    


    July 2018
  22. PATEL BN, Rosenberg M, Vernuccio F, Ramirez-Giraldo JC, et al
    Characterization of Small Incidental Indeterminate Hypoattenuating Hepatic Lesions: Added Value of Single-Phase Contrast-Enhanced Dual-Energy CT Material Attenuation Analysis.
    AJR Am J Roentgenol. 2018 Jul 24:1-9. doi: 10.2214/AJR.17.19170.
    PubMed     Text format     Abstract available


  23. PICKHARDT PJ, Graffy PM, Reeder SB, Hernando D, et al
    Quantification of Liver Fat Content With Unenhanced MDCT: Phantom and Clinical Correlation With MRI Proton Density Fat Fraction.
    AJR Am J Roentgenol. 2018 Jul 17:W1-W7. doi: 10.2214/AJR.17.19391.
    PubMed     Text format     Abstract available


  24. KIM DK, Choi JI, Choi MH, Park MY, et al
    Prediction of Posthepatectomy Liver Failure: MRI With Hepatocyte-Specific Contrast Agent Versus Indocyanine Green Clearance Test.
    AJR Am J Roentgenol. 2018 Jul 11:1-8. doi: 10.2214/AJR.17.19206.
    PubMed     Text format     Abstract available


  25. ELSAYES KM, Chernyak V, Morshid AI, Tang A, et al
    Spectrum of Pitfalls, Pseudolesions, and Potential Misdiagnoses in Cirrhosis.
    AJR Am J Roentgenol. 2018;211:87-96.
    PubMed     Text format     Abstract available


    May 2018
  26. JHA RC, Khera SS, Kalaria AD
    Portal Vein Thrombosis: Imaging the Spectrum of Disease With an Emphasis on MRI Features.
    AJR Am J Roentgenol. 2018 May 24:1-11. doi: 10.2214/AJR.18.19548.
    PubMed     Text format     Abstract available


    April 2018
  27. KITAO A, Matsui O, Yoneda N, Kita R, et al
    Differentiation Between Hepatocellular Carcinoma Showing Hyperintensity on the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI and Focal Nodular Hyperplasia by CT and MRI.
    AJR Am J Roentgenol. 2018 Apr 30:1-11. doi: 10.2214/AJR.17.19341.
    PubMed     Text format     Abstract available


  28. WEINSTEIN JL, Ahmed M
    Percutaneous Ablation for Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2018 Apr 27:1-8. doi: 10.2214/AJR.17.18695.
    PubMed     Text format     Abstract available


  29. NAUGLER WE
    Battle Royale: Systemic Versus Locoregional Therapy for Unresectable Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2018 Apr 18:1-2. doi: 10.2214/AJR.17.19392.
    PubMed     Text format     Abstract available


  30. PATNANA M, Menias CO, Pickhardt PJ, Elshikh M, et al
    Liver Calcifications and Calcified Liver Masses: Pattern Recognition Approach on CT.
    AJR Am J Roentgenol. 2018 Apr 18:1-11. doi: 10.2214/AJR.18.19704.
    PubMed     Text format     Abstract available


  31. KWAN SW, Harris WP, Gold LS, Hebert PL, et al
    Comparative Effectiveness of Transarterial Embolization and Sorafenib for Hepatocellular Carcinoma: A Population-Based Study.
    AJR Am J Roentgenol. 2018 Apr 9:1-7. doi: 10.2214/AJR.17.19094.
    PubMed     Text format     Abstract available


  32. ALLEN BC, Ho LM, Jaffe TA, Miller CM, et al
    Comparison of Visualization Rates of LI-RADS Version 2014 Major Features With IV Gadobenate Dimeglumine or Gadoxetate Disodium in Patients at Risk for Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2018 Apr 9:1-7. doi: 10.2214/AJR.17.18981.
    PubMed     Text format     Abstract available


  33. NAKAI Y, Gonoi W, Hagiwara A, Nishioka Y, et al
    MRI Detection of Intratumoral Fat in Colorectal Liver Metastases After Preoperative Chemotherapy.
    AJR Am J Roentgenol. 2018 Apr 9:W1-W9. doi: 10.2214/AJR.17.18814.
    PubMed     Text format     Abstract available


  34. WALSER EM
    Lollipops.
    AJR Am J Roentgenol. 2018;210:W182.
    PubMed     Text format    


    March 2018
  35. SUH CH, Kim KW, Park SH, Lee SS, et al
    Shear Wave Elastography as a Quantitative Biomarker of Clinically Significant Portal Hypertension: A Systematic Review and Meta-Analysis.
    AJR Am J Roentgenol. 2018 Mar 23:W1-W11. doi: 10.2214/AJR.17.18367.
    PubMed     Text format     Abstract available


  36. RAGHAVAN K, Jeffrey RB, Olcott EW
    Radiologic Evaluation of Intrahepatic Cholangiocarcinoma Perineural Invasion.
    AJR Am J Roentgenol. 2018;210:W129.
    PubMed     Text format    


  37. SEO N, Kim DY, Choi JY
    Reply to "Radiologic Evaluation of Intrahepatic Cholangiocarcinoma Perineural Invasion".
    AJR Am J Roentgenol. 2018;210:W130.
    PubMed     Text format    


    February 2018
  38. POULLOS PD, Tseng JJ, Melcher ML, Concepcion W, et al
    Structured Reporting of Multiphasic CT for Hepatocellular Carcinoma: Effect on Staging and Suitability for Transplant.
    AJR Am J Roentgenol. 2018 Feb 22:1-9. doi: 10.2214/AJR.17.18725.
    PubMed     Text format     Abstract available


  39. HIROOKA M, Hiraoka A, Ochi H, Kisaka Y, et al
    Transcatheter Arterial Chemoembolization With or Without Radiofrequency Ablation: Outcomes in Patients With Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2018 Feb 7:1-8. doi: 10.2214/AJR.17.18177.
    PubMed     Text format     Abstract available


    January 2018
  40. GUPTA S, Arellano RS, Gervais DA, Sahani DV, et al
    Assessing the Effect of Weight-Based Protocol Modifications to Lower Dose for CT-Guided Hepatic and Renal Tumor Radiofrequency Ablations.
    AJR Am J Roentgenol. 2018 Jan 11:1-6. doi: 10.2214/AJR.17.17952.
    PubMed     Text format     Abstract available


  41. FURLAN A, Brancatelli G, Burgio MD, Grazioli L, et al
    Focal Nodular Hyperplasia After Treatment With Oxaliplatin: A Multiinstitutional Series of Cases Diagnosed at MRI.
    AJR Am J Roentgenol. 2018 Jan 11:1-5. doi: 10.2214/AJR.17.18867.
    PubMed     Text format     Abstract available


  42. TUBLIN ME, Blair R, Martin J, Malik S, et al
    Prospective Study of the Impact of Liver Biopsy Core Size on Specimen Adequacy and Procedural Complications.
    AJR Am J Roentgenol. 2018;210:183-188.
    PubMed     Text format     Abstract available


    December 2017
  43. CUI J, Smolinski SE, Liu F, Xu D, et al
    Incrementally Expandable Transjugular Intrahepatic Portosystemic Shunts: Single-Center Experience.
    AJR Am J Roentgenol. 2017 Dec 20:1-9. doi: 10.2214/AJR.17.18222.
    PubMed     Text format     Abstract available


  44. PANG EHT, Chan A, Ho SG, Harris AC, et al
    Contrast-Enhanced Ultrasound of the Liver: Optimizing Technique and Clinical Applications.
    AJR Am J Roentgenol. 2017 Dec 8:1-13. doi: 10.2214/AJR.17.17843.
    PubMed     Text format     Abstract available


    November 2017
  45. SUH CH, Kim KW, Park SH, Kim SY, et al
    Performing Gadoxetic Acid-Enhanced MRI After CT for Guiding Curative Treatment of Early-Stage Hepatocellular Carcinoma: A Cost-Effectiveness Analysis.
    AJR Am J Roentgenol. 2017 Nov 1:W1-W7. doi: 10.2214/AJR.17.18300.
    PubMed     Text format     Abstract available


  46. PIERCE DB, Johnson GE, Monroe E, Loggers ET, et al
    Safety and Efficacy Outcomes of Embolization in Hepatic Sarcomas.
    AJR Am J Roentgenol. 2017 Nov 1:1-8. doi: 10.2214/AJR.16.17573.
    PubMed     Text format     Abstract available


  47. SEMAAN S, Makkar J, Lewis S, Chatterji M, et al
    Imaging of Hepatocellular Carcinoma Response After 90Y Radioembolization.
    AJR Am J Roentgenol. 2017;209:W263-W276.
    PubMed     Text format     Abstract available


    October 2017
  48. COSTA AF, Thipphavong S, Arnason T, Stueck AE, et al
    Fat-Containing Liver Lesions on Imaging: Detection and Differential Diagnosis.
    AJR Am J Roentgenol. 2017 Oct 24:1-10. doi: 10.2214/AJR.17.18136.
    PubMed     Text format     Abstract available


  49. ABRAMSON RG, Lakomkin N, Hainline A, Kang H, et al
    The Attenuation Distribution Across the Long Axis of Breast Cancer Liver Metastases at CT: A Quantitative Biomarker for Predicting Overall Survival.
    AJR Am J Roentgenol. 2017 Oct 24:W1-W7. doi: 10.2214/AJR.17.18249.
    PubMed     Text format     Abstract available


  50. DILLMAN JR, Trout AT, Costello EN, Serai SD, et al
    Quantitative Liver MRI-Biopsy Correlation in Pediatric and Young Adult Patients With Nonalcoholic Fatty Liver Disease: Can One Be Used to Predict the Other?
    AJR Am J Roentgenol. 2017 Oct 18:1-9. doi: 10.2214/AJR.17.18446.
    PubMed     Text format     Abstract available


  51. CHOI HH, Manning MA, Mehrotra AK, Wagner S, et al
    Primary Hepatic Neoplasms of Vascular Origin: Key Imaging Features and Differential Diagnoses With Radiology-Pathology Correlation.
    AJR Am J Roentgenol. 2017 Oct 12:W1-W10. doi: 10.2214/AJR.17.18100.
    PubMed     Text format     Abstract available


  52. CORWIN MT, Lee AY, Fananapazir G, Loehfelm TW, et al
    Nonstandardized Terminology to Describe Focal Liver Lesions in Patients at Risk for Hepatocellular Carcinoma: Implications Regarding Clinical Communication.
    AJR Am J Roentgenol. 2017 Oct 12:1-6. doi: 10.2214/AJR.17.18416.
    PubMed     Text format     Abstract available


  53. KATO A, Nakamoto Y, Ishimori T, Seo S, et al
    Predictability of 99mTc-Galactosyl Human Serum Albumin Scintigraphy for Posthepatectomy Liver Failure.
    AJR Am J Roentgenol. 2017 Oct 12:1-8. doi: 10.2214/AJR.17.18411.
    PubMed     Text format     Abstract available


  54. GOMES AS, Monteleone PA, Sayre JW, Finn RS, et al
    Comparison of Triple-Drug Transcatheter Arterial Chemoembolization (TACE) With Single-Drug TACE Using Doxorubicin-Eluting Beads: Long-Term Survival in 313 Patients.
    AJR Am J Roentgenol. 2017;209:722-732.
    PubMed     Text format     Abstract available


    September 2017
  55. GLAZER DI, Tatli S, Shyn PB, Vangel MG, et al
    Percutaneous Image-Guided Cryoablation of Hepatic Tumors: Single-Center Experience With Intermediate to Long-Term Outcomes.
    AJR Am J Roentgenol. 2017 Sep 27:1-9. doi: 10.2214/AJR.16.17582.
    PubMed     Text format     Abstract available


  56. CAMPO CA, Hernando D, Schubert T, Bookwalter CA, et al
    Standardized Approach for ROI-Based Measurements of Proton Density Fat Fraction and R2* in the Liver.
    AJR Am J Roentgenol. 2017;209:592-603.
    PubMed     Text format     Abstract available


  57. ISHIKAWA T, Aibe Y, Matsuda T, Iwamoto T, et al
    Plasma Glucose Level Is Predictive of Serum Ammonia Level After Retrograde Occlusion of Portosystemic Shunts.
    AJR Am J Roentgenol. 2017;209:W169-W176.
    PubMed     Text format     Abstract available


    August 2017
  58. CHEN HJ, Liu PF, Chen QF, Shi HB, et al
    Brain Microstructural Abnormalities in Patients With Cirrhosis Without Overt Hepatic Encephalopathy: A Voxel-Based Diffusion Kurtosis Imaging Study.
    AJR Am J Roentgenol. 2017 Aug 16:1-8. doi: 10.2214/AJR.17.17827.
    PubMed     Text format     Abstract available


  59. HAN NY, Park BJ, Yang KS, Kim MJ, et al
    Hepatic Parenchymal Heterogeneity as a Marker for Oxaliplatin-Induced Sinusoidal Obstruction Syndrome: Correlation With Treatment Response of Colorectal Cancer Liver Metastases.
    AJR Am J Roentgenol. 2017 Aug 16:1-7. doi: 10.2214/AJR.16.17528.
    PubMed     Text format     Abstract available


  60. PARK HJ, Kim JH, Choi SY, Lee ES, et al
    Prediction of Therapeutic Response of Hepatocellular Carcinoma to Transcatheter Arterial Chemoembolization Based on Pretherapeutic Dynamic CT and Textural Findings.
    AJR Am J Roentgenol. 2017 Aug 16:W1-W10. doi: 10.2214/AJR.16.17398.
    PubMed     Text format     Abstract available


  61. LI F, Han J, Han F, Wang JW, et al
    Combined Hepatocellular Cholang iocarcinoma (Biphenotypic) Tumors: Potential Role of Contrast-Enhanced Ultrasound in Diagnosis.
    AJR Am J Roentgenol. 2017 Aug 4:1-8. doi: 10.2214/AJR.16.17513.
    PubMed     Text format     Abstract available


  62. JADVAR H
    Targeted Radionuclide Therapy: An Evolution Toward Precision Cancer Treatment.
    AJR Am J Roentgenol. 2017;209:277-288.
    PubMed     Text format     Abstract available


  63. SUGITA R, Ito K, Noda Y
    Reply to "Biliopancreatic Reflux Shown on Gadoxetic Acid-Enhanced MRI".
    AJR Am J Roentgenol. 2017;209:W118.
    PubMed     Text format    


  64. KARAOSMANOGLU AD, Karcaaltincaba M
    Biliopancreatic Reflux Shown on Gadoxetic Acid-Enhanced MRI.
    AJR Am J Roentgenol. 2017;209:W117.
    PubMed     Text format    


    July 2017
  65. SUH CH, Kim KW, Pyo J, Lee J, et al
    Hypervascular Transformation of Hypovascular Hypointense Nodules in the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI: A Systematic Review and Meta-Analysis.
    AJR Am J Roentgenol. 2017 Jul 25:1-9. doi: 10.2214/AJR.16.17711.
    PubMed     Text format     Abstract available


  66. HAIDER SJ, Tarulli M, McNulty NJ, Hoffer EK, et al
    Liver Abscesses: Factors That Influence Outcome of Percutaneous Drainage.
    AJR Am J Roentgenol. 2017;209:205-213.
    PubMed     Text format     Abstract available


    June 2017
  67. AN C, Park S, Chung YE, Kim DY, et al
    Curative Resection of Single Primary Hepatic Malignancy: Liver Imaging Reporting and Data System Category LR-M Portends a Worse Prognosis.
    AJR Am J Roentgenol. 2017 Jun 28:1-8. doi: 10.2214/AJR.16.17478.
    PubMed     Text format     Abstract available


  68. AHMAD T, Chavhan GB, Avitzur Y, Moineddin R, et al
    Doppler Parameters of the Hepatic Artery as Predictors of Graft Status in Pediatric Liver Transplantation.
    AJR Am J Roentgenol. 2017 Jun 28:1-5. doi: 10.2214/AJR.17.17902.
    PubMed     Text format     Abstract available


  69. CORVINO A, Catalano O, Corvino F, Sandomenico F, et al
    Diagnostic Performance and Confidence of Contrast-Enhanced Ultrasound in the Differential Diagnosis of Cystic and Cysticlike Liver Lesions.
    AJR Am J Roentgenol. 2017 Jun 22:W1-W9. doi: 10.2214/AJR.16.17062.
    PubMed     Text format     Abstract available


  70. CHOI SH, Kim SY, Lee SS, Shim JH, et al
    Subtraction Images of Gadoxetic Acid-Enhanced MRI: Effect on the Diagnostic Performance for Focal Hepatic Lesions in Patients at Risk for Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2017 Jun 13:1-8. doi: 10.2214/AJR.16.17211.
    PubMed     Text format     Abstract available


  71. SEO N, Kim DY, Choi JY
    Cross-Sectional Imaging of Intrahepatic Cholangiocarcinoma: Development, Growth, Spread, and Prognosis.
    AJR Am J Roentgenol. 2017 Jun 1:W1-W12. doi: 10.2214/AJR.16.16923.
    PubMed     Text format     Abstract available


  72. CEKIC B, Toslak IE, Sahinturk Y, Cekin AH, et al
    Differentiating Transudative From Exudative Ascites Using Quantitative B-Mode Gray-Scale Ultrasound Histogram.
    AJR Am J Roentgenol. 2017 Jun 1:1-7. doi: 10.2214/AJR.16.16509.
    PubMed     Text format     Abstract available


  73. BRAILLON A
    Transarterial Radioembolization for Hepatocellular Carcinoma Is Safe, but Is It Effective?
    AJR Am J Roentgenol. 2017;208:W241.
    PubMed     Text format    


    May 2017
  74. DUNPHY M, Pandit-Taskar N, Fox JJ, Kemeny N, et al
    The Precision of Hepatic Arterial Infusion Scintigraphy as a Quantitative Biomarker of Tumor Microvasculature.
    AJR Am J Roentgenol. 2017 May 24:1-5. doi: 10.2214/AJR.16.17560.
    PubMed     Text format     Abstract available


  75. ALIBERTI C, Carandina R, Sarti D, Mulazzani L, et al
    Chemoembolization Adopting Polyethylene Glycol Drug-Eluting Embolics Loaded With Doxorubicin for the Treatment of Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2017 May 24:1-5. doi: 10.2214/AJR.16.17477.
    PubMed     Text format     Abstract available


  76. TIPIRNENI-SAJJA A, Krafft AJ, McCarville MB, Loeffler RB, et al
    Radial Ultrashort TE Imaging Removes the Need for Breath-Holding in Hepatic Iron Overload Quantification by R2* MRI.
    AJR Am J Roentgenol. 2017 May 15:1-8. doi: 10.2214/AJR.16.17183.
    PubMed     Text format     Abstract available


  77. KELLER EJ, Kulik L, Stankovic Z, Lewandowski RJ, et al
    JOURNAL CLUB: Four-Dimensional Flow MRI-Based Splenic Flow Index for Predicting Cirrhosis-Associated Hypersplenism.
    AJR Am J Roentgenol. 2017 May 2:1-9. doi: 10.2214/AJR.16.17620.
    PubMed     Text format     Abstract available


    March 2017
  78. COVEY AM, Hussain SM
    Liver-Directed Therapy for Hepatocellular Carcinoma: An Overview of Techniques, Outcomes, and Posttreatment Imaging Findings.
    AJR Am J Roentgenol. 2017 Mar 28:1-10. doi: 10.2214/AJR.17.17799.
    PubMed     Text format     Abstract available


  79. PAIGE JS, Bernstein GS, Heba E, Costa EA, et al
    A Pilot Comparative Study of Quantitative Ultrasound, Conventional Ultrasound, and MRI for Predicting Histology-Determined Steatosis Grade in Adult Nonalcoholic Fatty Liver Disease.
    AJR Am J Roentgenol. 2017 Mar 7:W1-W10. doi: 10.2214/AJR.16.16726.
    PubMed     Text format     Abstract available


  80. SARWAR A, Esparaz AM, Tapper EB, Brook OR, et al
    Comparison of Vascular Plugs and Pushable Coils for Variceal Embolization After TIPS.
    AJR Am J Roentgenol. 2017;208:650-655.
    PubMed     Text format     Abstract available


    August 2016
  81. CANELLAS R, Mehrkhani F, Patino M, Kambadakone A, et al
    Characterization of Portal Vein Thrombosis (Neoplastic Versus Bland) on CT Images Using Software-Based Texture Analysis and Thrombus Density (Hounsfield Units).
    AJR Am J Roentgenol. 2016.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: